The leading global voice
We play a major role in bringing the CV community together to drive transformational change.
Together we are stronger
By 2025, our aim is to reduce premature deaths from CVD by at least 25%.
Join the fight
Become a WHF member and help us to build global commitment to address cardiovascular health at the policy level.
We convene and connect our members
To share science, best practice and resources, acting as a global thought leader and catalyst for positive change.
Celebrate World Heart Day
The biggest global awareness-raising campaign for CVD.
Attend the Congress
Join world leaders in heart health, share ideas, network with specialists.
Advocating for heart health
We lead the global advocacy effort for action to prevent, control and reduce the global burden of CVD.
All our programmes and partnerships are aimed at creating awareness of CVD as a priority issue across the globe.
Find out more about our and our members' work around the world.
Explore everything from toolkits, videos and infographics, to policy reports, factsheets and more.
Throughout August and September, a number of Members of the World Heart Federation participated in the Committee Meetings for four WHO (World Health Organization) regions: Africa, Europe, Southeast Asia and the Americas.
Taking place annually, the regional meetings are held to determine regional health policy and to approve programmes of work, and each of the 6 WHO regional meetings is guided by a specific agenda.
The Pan-African Society of Cardiology (PASCAR), Dutch Heart Foundation (DHF), Tiny Hearts of Maldives (THM) and the Inter-American Heart Foundation (IAHF) all participated in their respective regions to promote cardiovascular health and advocate to governments on the urgent need for action on heart disease and stroke.
Following the decision by the WHO Executive Board in June to recommend a Resolution on rheumatic fever and rheumatic heart disease for adoption in 2018, the Regional Meetings also offered a valuable opportunity to further press the case for global policy on this preventable disease.
Policy Statements at the Regional Meetings
At the Regional Meeting for Africa – held in Victoria Falls, Zimbabwe – WHF were represented by Jeremiah Mwangi of the World Heart Federation and Associate Professor Liesl Zühlke of PASCAR and the University of Cape Town. Policy statements at this meeting focused on the need to include RHD interventions in universal health coverage packages and on the contribution of environmental determinants to CVD risk.
In the following week, Professor Anita Saxena of the All India Institute for Medical Sciences and Jeehan Mahmood (THM) participated in the regional meeting for Southeast Asia in Malé, the Maldives.
At both the SEARO meeting and European regional meeting in Budapest – attended by Dr Anne Belonje (DHF) – delegates delivered policy statements on access to medicines, drawing attention to ongoing shortages of benzathine penicillin G (BPG) – the essential antibiotic for primary and secondary prevention of rheumatic fever and RHD – and the need to increase the resources allocated to CVD medicines in national health budgets.
Taking place in the final week of September, the 29th Pan-American Sanitary Conference was attended by Beatriz Champagne of IAHF, who advocated strongly on healthy eating, the importance of non-communicable diseases to sustainable development, and rheumatic heart disease.
Two regional meetings still remain – these will take place this month, and will be held in:
Stay tuned to receive more updates via Members’ News, social media and our website.
You can read the World Heart Federation’s policy statements in full here.
Some photos from the regional meetings:
Jeehan Mahmood (left) and Prof. Anita Saxena (centre)
Anne Belonje delivers policy statement on access to CVD medicines
Diana Vaca McGhie (left) and Beatriz Champagne (right) with Dr. Tedros (centre)
Beatriz Champagne delivers statement on rheumatic heart disease
WHF participates in the ACC Scientific Sessions
'Nursing Now' campaign launched
Special Session on CVD and tobacco at the World Conference on Tobacco or Health